The rulebook for rare disease treatments will be overhauled to make it quicker and easier to get these therapies tested, ...

Swiss pharma major Roche (ROG: SIX) has reported positive Phase III data for Gazyva (obinutuzumab) in systemic lupus ...

Irish healthcare group Uniphar (LSE: UPR) has unified its US businesses under one banner, rebranding RRD Biopharma ...

UK-based specialty CNS-focused pharma company CNX Therapeutics says it has acquired the global Sativex (nabiximols) business ...

Pfizer today announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk in the US District Court for the District of Delaware.

Germany-based Immatics has this month announced updated clinical data from its PRAME-directed TCR T-cell therapy, anzu-cel (anzutresgene autoleucel, IMA203), in 16 patients with metastatic uveal ...

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to challenge multinational dominance.

Pharmacovigilance (PV) is a crucial process used by pharmaceutical companies, healthcare professionals and regulators in identifying, evaluating and preventing adverse drug reactions.

The US Food and Drug Administration (FDA) has approved German pharma major Bayer’s Lynkuet (elinzanetant) 60mg capsules, the ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

Germany-based biotech Tubulis today announced a second and final closing of its Series C round totaling 344 million euros ...

US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...